Applied Genetic Technologies Corporation (AGTC) was founded by five scientific leaders in the use of viral vectors for Gene Therapy and began operations in 2001. They subsequently secured rights to a portfolio of strategically vital intellectual property in the application of Adeno-Associated Virus (AAV) to gene therapy. Since that time the Company has signed licenses to over 40 US and foreign patents, raised over $45M in venture financing from blue chip investors and has five products in active development, one of which is partnered to Genzyme Corporation.
AGTC's most recent round of financing was completed in April 2009 and was led by Interwest Partners of Menlo Park, CA. Other investors included Intersouth Partners of RTP, NC and MedImmune Ventures of Gaithersburg, MD.
Current Team (3)Update
Funding Rounds (5) - $78.1MUpdate
Board Members and Advisors (5)Update
InterWest invests an average of about $7 - 15 million over the span of their involvement with...
Intersouth Partners is one of the most active and experienced venture funds in the Southeast,...
Alta Partners is a leading venture capital firm in life sciences, funding over 130 companies in...
Osage University Partners is a venture capital fund investing in start-ups that commercialize...
Skyline Ventures, formed in 1997, is a nationally-known venture capital firm that specializes in...
11801 Research Drive
Alachua, FL 32615